This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Idroxioleic acid
- DrugBank Accession Number
- DB18213
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
Structure for Idroxioleic acid (DB18213)
- Weight
- Average: 298.467
Monoisotopic: 298.250794955 - Chemical Formula
- C18H34O3
- Synonyms
- (z)-2-hydroxyoctadec-9-enoic acid
- 2-hydroxyoleic acid
- 9-octadecenoic acid, 2-hydroxy-, (9z)-
- Alpha-hydroxyoleic acid
- Cis-2-hydroxy-9-octadecenoic acid
- Minerval
- Rac-(2r,9z)-2-hydroxyoctadec-9-enoic acid
- External IDs
- 2-OHOA
- NFX-88
- NFX88
- SML-0256
- SML0256
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- OSV3KVO1BT
- CAS number
- 56472-29-8
- InChI Key
- JBSOOFITVPOOSY-KTKRTIGZSA-N
- InChI
- InChI=1S/C18H34O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17(19)18(20)21/h9-10,17,19H,2-8,11-16H2,1H3,(H,20,21)/b10-9-
- IUPAC Name
- (9Z)-2-hydroxyoctadec-9-enoic acid
- SMILES
- CCCCCCCC\C=C/CCCCCCC(O)C(O)=O
References
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Completed Treatment Neuropathic Pain / Spinal Cord Injuries 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 5.91 Chemaxon pKa (Strongest Acidic) 4.29 Chemaxon pKa (Strongest Basic) -3.8 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 57.53 Å2 Chemaxon Rotatable Bond Count 15 Chemaxon Refractivity 88.89 m3·mol-1 Chemaxon Polarizability 37.83 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at September 13, 2023 21:17 / Updated at September 15, 2023 10:38